SCHEMBL8358586

SCHEMBL8358586

COc1ccc2[nH]c(C(C)(C)C)[c]c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.47
ALDH1A1 P00352 4/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
HSD17B10 Q99714 3/20 0.47
MAPT P10636 3/20 0.47
GFER P55789 2/20 0.47
TSHR P16473 1/20 0.47
HPGD P15428 4/20 0.43
AXL P30530 1/20 0.42
PSMB8 P28062 2/20 0.40
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
LOXL2 Q9Y4K0 1/20 0.38
PDGFRB P09619 1/20 0.38
PDGFRA P16234 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
ACHE P22303 1/20 0.37
ABCG2 Q9UNQ0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2074318 0.79 KDM4E (0.50) KDM4EALDH1A1MEN1KMT2AHSD17B10
SCHEMBL8356350 0.75 KDM4E (0.46) KDM4EALDH1A1MEN1KMT2AHSD17B10
SCHEMBL10492171 0.75 HSD17B10 (0.46) KDM4EALDH1A1MEN1KMT2AHSD17B10
SCHEMBL1076963 0.72 KDM4E (0.48) KDM4EALDH1A1MEN1KMT2AHSD17B10
SCHEMBL4316072 0.67 AXL (0.66) KDM4EALDH1A1MEN1KMT2AHSD17B10
SCHEMBL11027233 0.66 CA1 (0.48) KDM4EALDH1A1MEN1KMT2AHSD17B10
SCHEMBL310518 0.66 ALDH1A1 (0.47) KDM4EALDH1A1MEN1KMT2AHSD17B10
SCHEMBL2439787 0.66 ALDH1A1 (0.47) KDM4EALDH1A1MEN1KMT2AHSD17B10
SCHEMBL29391519 0.65 ALDH1A1 (1.00) KDM4EALDH1A1MEN1KMT2AHSD17B10
SCHEMBL2597652 0.65 ALDH1A1 (1.00) KDM4EALDH1A1MEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5877202-A Indole derivatives useful to treat estrogen-related neoplasms and disorders AVENTISUB II INC. 1999-03-02 US disclosed